Yelizaveta Y Gribkova

Department of Surgery, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, USA.

1 publication 2024 – 2024

What does Yelizaveta Y Gribkova research?

Dr. Gribkova studies the effectiveness of treatments for peritoneal carcinomatosis, a type of cancer that spreads to the abdominal cavity. She specifically investigates a surgical procedure called CRS/HIPEC, which combines tumor removal with heated chemotherapy. Her research aims to understand how the number of these procedures performed by hospitals influences patient outcomes, such as complications and recovery times.

Key findings

  • In a study of over 5,000 CRS/HIPEC procedures across 149 hospitals, there was no significant difference in patient outcomes based on hospital volume.
  • Patients at low-volume hospitals did not experience worse overall results, despite a higher transfer rate to the ICU after surgery.
  • Both high- and low-volume hospitals showed similar rates of complications, deaths, hospital stays, and readmissions.

Frequently asked questions

Does Dr. Gribkova study cancer treatments?
Yes, she focuses on innovative surgical treatments for peritoneal carcinomatosis.
What specific treatment does Dr. Gribkova research?
She researches the CRS/HIPEC procedure, which involves removing abdominal tumors and applying heated chemotherapy.
Is Dr. Gribkova's work relevant to hospitals with low surgery volumes?
Yes, her findings indicate that low-volume hospitals can achieve comparable patient outcomes to higher-volume hospitals for CRS/HIPEC.

Publications in plain English

Does Hospital Operative Volume Influence the Outcomes of Patients After Heated Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis?

2024

Annals of surgical oncology

Chatani PD, Manzella A, Gribkova YY, Ecker BL, Beninato T +3 more

Plain English
Researchers looked at whether hospitals that perform more of a specific cancer surgery (called CRS/HIPEC, which involves removing tumors and bathing the abdomen with heated chemotherapy) get better results than hospitals that do fewer of these operations. They examined over 5,000 procedures across 149 hospitals between 2020 and 2022. They found no meaningful difference in patient outcomes—including complications, deaths, hospital stays, or readmissions—regardless of whether a hospital performed 4 cases a year or 47 cases a year. The only minor difference was that low-volume hospitals sent more patients to the ICU after surgery, but this didn't translate to worse overall results. This matters because it shows that for this particular procedure, hospitals don't need to do hundreds of these surgeries to get good results—experience at a basic level is apparently enough, at least in well-equipped academic medical centers.

PubMed

Publication data sourced from PubMed . Plain-English summaries generated by AI. Not medical advice.